![PPT - Actualité dans le traitement pharmacologique de l'Ataxie Télangiectasie PowerPoint Presentation - ID:1557645 PPT - Actualité dans le traitement pharmacologique de l'Ataxie Télangiectasie PowerPoint Presentation - ID:1557645](https://image1.slideserve.com/1557645/slide7-l.jpg)
PPT - Actualité dans le traitement pharmacologique de l'Ataxie Télangiectasie PowerPoint Presentation - ID:1557645
![Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells - ScienceDirect Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1873506116301052-fx1.jpg)
Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells - ScienceDirect
![Cancers | Free Full-Text | Bone Marrow Transplantation as Therapy for Ataxia -Telangiectasia: A Systematic Review Cancers | Free Full-Text | Bone Marrow Transplantation as Therapy for Ataxia -Telangiectasia: A Systematic Review](https://www.mdpi.com/cancers/cancers-12-03207/article_deploy/html/images/cancers-12-03207-g001.png)
Cancers | Free Full-Text | Bone Marrow Transplantation as Therapy for Ataxia -Telangiectasia: A Systematic Review
![U.S. FDA Partial Clinical Hold Lifted on IND for EryDel's Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia | Business Wire U.S. FDA Partial Clinical Hold Lifted on IND for EryDel's Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia | Business Wire](https://mms.businesswire.com/media/20230928420547/en/1528430/23/Quince_Therapeutics_Logo.jpg)